Literature DB >> 14631323

Are silent coronary stenoses predictable in diabetic patients and predictive of cardiovascular events?

E Cosson1, M Guimfack, J Paries, F Paycha, J R Attali, P Valensi.   

Abstract

OBJECTIVES: We have previously shown that silent coronary stenoses (CS) were predictors of subsequent major cardiac events in diabetic patients with silent myocardial ischemia (SMI). The aim of this study was to determine their correlates and their prognostic value for other cardiovascular events.
METHODS: 362 asymptomatic diabetic patients, without prior myocardial infarction, with > or =1 additional risk factor and a normal resting electrocardiogram underwent a myocardial scintigraphy to detect SMI. The patients with SMI subsequently underwent a coronary angiography to detect CS. A total of 345 (95.3%) patients were followed up for 41 +/- 24 months with regard to the occurrence of stroke, gangrene or a peripheral revascularization procedure, exercise occurrence of angina, and nonfatal arrhythmia.
RESULTS: 121 patients had SMI and 44 had CS. The univariate correlates of CS were age > 65 years (Odds Ratio 2.1 [CI 95%: 1.1-4.0]; p=0.021), male gender (OR 3.1 [1.5-6.3]; p=0.001), smoking (OR 2.8 [1.4-5.6]; p=0.004), > or =2 risk factors (OR 2.1 [1.09-4.09]; p=0.024) and peripheral arterial disease (OR 3.2 [1.2-8.7]; p=0.018). Logistic regression showed that age > 65 years (p=0.034), male gender (p=0.001) and > or =2 risk factors (p=0.013) were independently associated with the presence of CS. The univariate predictors of the 16 minor events were peripheral arterial disease (OR 8.8 [2.7-28.5]; p<0.001), CS (OR 4.9 [1.7-14.2]; p=0.002), SMI (OR 3.7, [1.3-10.5]; p=0.009) and smoking (OR 3.2 [1.1-9.2]; p=0.024). In the multivariate analysis, arterial occlusive disease (p<0.001), smoking (p<0.036) and CS (p=0.044) were independent predictors of events.
CONCLUSION: Silent CS predict major cardiac events but also other cardiovascular events and are more common in diabetic patients > 65 years-old, of male gender and with > or =2 risk factors.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14631323     DOI: 10.1016/s1262-3636(07)70060-5

Source DB:  PubMed          Journal:  Diabetes Metab        ISSN: 1262-3636            Impact factor:   6.041


  10 in total

1.  A Case of Transient ST Elevation and Polymorphic Tachycardia without Angina Diagnosed by Holter Monitoring.

Authors:  Ali Farooq; Fahad Alqahtani; Almoutassim Trabulsi; Akram Kawsara; Mohamad Alkhouli
Journal:  Cureus       Date:  2017-05-25

Review 2.  The clinical significance of continuous ECG (ambulatory ECG or Holter) monitoring of the ST-segment to evaluate ischemia: a review.

Authors:  Neil J Wimmer; Benjamin M Scirica; Peter H Stone
Journal:  Prog Cardiovasc Dis       Date:  2013-08-16       Impact factor: 8.194

3.  Prevalence of symptomatic and silent stress-induced perfusion defects in diabetic patients with suspected coronary artery disease referred for myocardial perfusion scintigraphy.

Authors:  John O Prior; David Monbaron; Melanie Koehli; Maria-Lucia Calcagni; Juan Ruiz; Angelika Bischof Delaloye
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-08-10       Impact factor: 9.236

4.  Cardiovascular risk prediction is improved by adding asymptomatic coronary status to routine risk assessment in type 2 diabetic patients.

Authors:  Emmanuel Cosson; Minh Tuan Nguyen; Bernard Chanu; Isabela Banu; Sabrina Chiheb; Cristina Balta; Karim Takbou; Paul Valensi
Journal:  Diabetes Care       Date:  2011-07-20       Impact factor: 19.112

5.  Asymptomatic coronary heart disease in patients with type 2 diabetes with vascular complications: a cross-sectional study.

Authors:  Tetsuro Tsujimoto; Hiroshi Kajio; Yoshihiko Takahashi; Miyako Kishimoto; Hiroshi Noto; Ritsuko Yamamoto-Honda; Munehiro Kamimura; Miyako Morooka; Kazuo Kubota; Takuro Shimbo; Michiaki Hiroe; Mitsuhiko Noda
Journal:  BMJ Open       Date:  2011-01-01       Impact factor: 2.692

6.  Type 1 diabetes: Developing the first risk-estimation model for predicting silent myocardial ischemia. The potential role of insulin resistance.

Authors:  Gemma Llauradó; Albert Cano; Cristina Hernández; Montserrat González-Sastre; Ato-Antonio Rodríguez; Jordi Puntí; Eugenio Berlanga; Lara Albert; Rafael Simó; Joan Vendrell; José-Miguel González Clemente
Journal:  PLoS One       Date:  2017-04-03       Impact factor: 3.240

7.  Glycation gap is associated with macroproteinuria but not with other complications in patients with type 2 diabetes.

Authors:  Emmanuel Cosson; Isabela Banu; Camille Cussac-Pillegand; Qinda Chen; Sabrina Chiheb; Yahya Jaber; Minh Tuan Nguyen; Nathalie Charnaux; Paul Valensi
Journal:  Diabetes Care       Date:  2013-02-01       Impact factor: 19.112

8.  Flow-mediated-paradoxical vasoconstriction is independently associated with asymptomatic myocardial ischemia and coronary artery disease in type 2 diabetic patients.

Authors:  Minh Tuan Nguyen; Isabelle Pham; Paul Valensi; Hélène Rousseau; Eric Vicaut; Christelle Laguillier-Morizot; Alain Nitenberg; Emmanuel Cosson
Journal:  Cardiovasc Diabetol       Date:  2014-01-15       Impact factor: 9.951

9.  Atherogenic dyslipidemia and risk of silent coronary artery disease in asymptomatic patients with type 2 diabetes: a cross-sectional study.

Authors:  Paul Valensi; Antoine Avignon; Ariane Sultan; Bernard Chanu; Minh Tuan Nguyen; Emmanuel Cosson
Journal:  Cardiovasc Diabetol       Date:  2016-07-22       Impact factor: 9.951

Review 10.  Risk stratification for coronary artery disease in multi-ethnic populations: Are there broader considerations for cost efficiency?

Authors:  Pupalan Iyngkaran; William Chan; Danny Liew; Jalal Zamani; John D Horowitz; Michael Jelinek; David L Hare; James A Shaw
Journal:  World J Methodol       Date:  2019-01-18
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.